Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

Dcspka,

There is a good reason why Gartner was not selling his lung cancer test. Prior to last month, he would have needed to pay Radient a license fee and royalties. Today, there is no need at all to pay Radient any fees at all. Radient's patent expired last month.

Gartner no longer has any need for any agreement with Radient.

I still do not think Gartner has found any significant investors but if he in fact begins to sell lung cancer tests, his chances of obtaining money increases greatly.

Why do I think they are looking for investors? Look at the comment by Jimtash where someone at GCDX looked at his linkedin page to see if he would possibly be an investor.


Gartner is now current with his hosting fees but the website is parked awaiting action by Gartner.